Skip to main content
. 2021 Sep 8;480(2):403–413. doi: 10.1007/s00428-021-03186-3

Fig. 2.

Fig. 2

Total number of samples, variants, tissue type material, and sequencing technology applied on 1663 cases for every target organ/site [whole-genome sequencing (WGS) (n = 22), whole-exome sequencing (WES) (n = 111), Sanger sequencing (n = 185), and high-throughput sequencing (HTS) (n = 1434)]; twenty-one HTS samples are from an unspecified organ of origin; the different types of tissue source, formalin-fixed paraffin-embedded (FFPE) tissue (n = 1327) or fresh frozen (FF) tissue (n = 478), are given for each organ/site